The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure

More documents

Recommendations

Info

Potential Causes of NT-proBNP Elevation Source: Januzzi et al, - Am J Cardiol (2008) 101: 29A-38A. 12
NT-proBNP in the Acute Setting 13
Page 1 and 2: The Use of NT-proBNP and BNP as Bio
Page 3 and 4: B-type Natriuretic Peptides Pre-Pro
Page 5 and 6: “Breathing Not Properly” Multin
Page 7 and 8: ValHeft Study: 2006 LVEF: left vent
Page 9 and 10: NT-proBNP Levels by Diagnosis in Pa
Page 11: VITROS ® NT-proBNP - Method Compar
Page 15 and 16: NT-proBNP Levels by Diagnosis in Pa
Page 17 and 18: NT-proBNP Levels Predict Survival i
Page 19 and 20: Age-independent Rule-out Cut-point
Page 21 and 22: NT-proBNP vs BNP for Acute Heart Fa
Page 23 and 24: VITROS ® NT-proBNP - Intended Use
Page 25 and 26: NT-proBNP-Tailored CHF Therapy The
Page 27 and 28: Study Endpoints •1 endpoint •To
Page 29 and 30: Primary Endpoint 100 events P =.009
Page 31 and 32: Events as a function of NT-proBNP P
Page 33: QUESTIONS 33

The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure

Create successful ePaper yourself

Delete template?

Save as template?